Stay updated on Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Sign up to get notified when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.
Latest updates to the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page
- Check6 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check57 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference4%
- Check72 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and providing detailed participant and study information, while removing the previous version v2.12.1.SummaryDifference4%
- Check79 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tesetaxel+PD-(L)1 Inhibitors in Triple-Negative MBC Clinical Trial page.